Caption Management’s iTeos Therapeutics ITOS Stock Holding History

Caption Management’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-18,200	Closed	-$140K	–	1792
2024 Q4	$140K	Sell	18,200 -284,000	-94%	-$2.44M	﹤0.01%	1315
2024 Q3	$3.09M	Buy	+302,200	New	+$4.61M	0.05%	435
2022 Q3	–	Sell	-51,000	Closed	-$1.05M	–	1671
2022 Q2	$1.05M	Buy	+51,000	New	+$1.21M	0.01%	865

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caption Management's ITOS Position: Q3 2025 in Review

Caption Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 22,157 shares — an estimated $221K sold.

Caption Management first reported a position in ITOS in Q1 2022 and held it in 6 quarters. The position peaked at $3.92M in Q4 2024. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Caption Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Caption Management sold 22,157 iTeos Therapeutics shares in Q3 2025, an estimated $221K.
Caption Management first reported a position in iTeos Therapeutics in Q1 2022 and held it in 6 quarters.
Caption Management's iTeos Therapeutics position peaked at $3.92M in Q4 2024.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Caption Management's 13F filing for Q3 2025, filed 14 Nov 2025.